Indicated for diabetes management but can aid in weight loss as off label.
- Regular price
- Regular price
- Sale price
Discreet and confidential
Includes free prescription
Professional advice and prompt support
Quick view Summary
Type of medicine
GLP-1 receptor agonist
Varies; starting dose of 0.25 mg weekly, increasing to 1 mg if needed
Reduce appetite and promote feelings of fullness.
1 mg solution for injection in pre-filled pen
Common side effects
Nausea, vomiting, diarrhea, hypoglycemia, stomach pain, dizziness, fatigue
Use with alcohol
Avoid excessive alcohol consumption; consult doctor for guidance
Ozempic (Semaglutide) is an injectable drug used to treat type 2 diabetes and it has a weight loss effect by reducing appetite and promoting feelings of fullness. It works by mimicking the effects of naturally occurring glucagon-like peptide 1 (GLP-1), which is a hormone that regulates appetite and glucose levels in the body. Ozempic is not indicated for Weight loss in the UK and is currently prescribed off-label.
The injection pen should be used as part of a comprehensive weight loss program that includes a healthy diet and physical activity.
Patients should always talk to their doctor about their medical history, any existing conditions, and potential drug interactions before starting treatment with Ozempic.
Patient information leaflet
Download patient information leaflet (PIL) on the link below:
Can Ozempic® be used as a standalone treatment for diabetes?
Is Ozempic® suitable for children and adolescents with diabetes?
How does Ozempic® compare to other diabetes medications like insulin?
Can Ozempic® be used by pregnant or breastfeeding individuals?
How does Ozempic® interact with other medications?
Medically reviewed and published
This page was medically reviewed by Dr Sohaib Imtiaz, Clinical Lead |
Got any questions?
Our customer service team is always here to help!
Reach out to us at anytime during normal working hours, Monday to Friday from 8am to 5pm.
Email us: email@example.com
You can also visit our Help Centre page for FAQs and for more articles to read.